COVID 19

DXB announces approval for Phase III COVID-19 trials

On Friday last week, DXB announced that the main drug regulator in India has recommended approval for DXB’s Phase III clinical trials on COVID-19 treatment, specifically for patients with respiratory complications intended for hospitalisation — its CLARITY 2.0 study.

CM8 Signs Vital European Sales Agreement for High Demand Healthcare Products

Crowd Media Holdings Limited (ASX:CM8 | FWB:CM3) and VITAL have joined together with a two-year exclusive and binding Marketing Services Agreement to market and sell key VITAL portfolio brands and products into the European market

Could a NASDAQ Listing Put MYQ on the US Health & Fitness Map?

Software as a service (SaaS) solution provider MyFiziq Limited (ASX: MYQ) is set for a secondary listing on the NASDAQ Capital Market.

ASX Listed Tech Stock’s Health App Can Help Fight Obesity and COVID-19

MyFiziq's (ASX: MYQ) technology allows for the easy collection and comparison of measurements for clothing, weight management, athletic goals, and the medical field treating illnesses such as diabetes and obesity..

Are you a sophisticated investor?
Find out more
Please note: Raisebook is a related entity of S3 Consortium Pty Ltd as defined in Section 9 of the Corporations Act 2001.

Thanks for subscribing!

X